Potential of [C-11]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy by Timmer, S.A.J. et al.
ORIGINAL ARTICLE
Potential of [11C]acetate for measuring
myocardial blood flow: Studies in normal
subjects and patients with hypertrophic
cardiomyopathy
S. A. J. Timmer, BSc,a M. Lubberink, PhD,a T. Germans, MD, PhD,b M. J. W. Go¨tte,
MD, PhD,b J. M. ten Berg, MD, PhD,c F. J. ten Cate, MD, PhD,d A. C. van Rossum,
MD, PhD,b A. A. Lammertsma, PhD,a and P. Knaapen, MD, PhDb
Background. Measuring the rate of clearance of carbon-11 labelled acetate from myo-
cardium using positron emission tomography (PET) is an accepted technique for noninvasively
assessing myocardial oxygen consumption. Initial myocardial uptake of [11C]acetate, however,
is related to myocardial blood flow (MBF) and several tracer kinetic models for quantifying
MBF using [11C]acetate have been proposed. The objective of this study was to assess these
models.
Methods. Eighteen healthy subjects and 18 patients with hypertrophic cardiomyopathy
(HCM) were studied under baseline conditions with [11C]acetate and [15O]water. Four previ-
ously reported methods, including single- and multi-tissue compartment models, were used to
calculate MBF from the measured [11C]acetate rate of influx K1 and the (previously) reported
relationship between K1 and MBF. These MBF values were then compared with those derived
from corresponding [15O]water studies.
Results. For all models, correlations between [11C]acetate and [15O]water-derived MBF
ranged from .67 to .86 (all P < .005) in the control group and from .73 to .85 (all P < .001) in the
HCM group. Two out of four models systematically underestimated perfusion with [11C]ace-
tate, whilst the third model resulted in an overestimation. The fourth model, based on a simple
single tissue compartment model with spillover, partial volume and recirculating metabolite
corrections, resulted in a regression equation with a slope of near unity and an Y-intercept of
almost zero (controls, K1 5 .74[MBF] 1 .09, r 5 .86, SEE 5 .13, P < .001 and HCM,
K1 5 .89[MBF] 1 .03, r 5 .85, SEE 5 .12, P < .001).
Conclusion. [11C]acetate enables quantification of MBF in fairly good agreement with
actual MBF in both healthy individuals and patients with HCM. A single tissue compartment
model with standardized correction for recirculating metabolites and with corrections for
partial volume and spillover provided the best results. (J Nucl Cardiol 2010;17:264–75.)
Key Words: Myocardial blood flow Æ [11C]acetate Æ [15O]water Æ positron emission
tomography Æ hypertrophic cardiomyopathy
INTRODUCTION
Carbon-11 labelled acetate is an established tracer for
the non-invasive evaluation of myocardial oxygen con-
sumption (MVO2) with positron emission tomography
(PET).1-5 Oxidative metabolism is related to the early rate
of clearance of tracer in the myocardium, whereas initial
tracer uptake is dependent on myocardial blood flow
(MBF). Therefore, it is tempting to derive simultaneous
information on MBF and MVO2 from a single dynamic
cardiac [11C]acetate study, despite the fact that
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quantification of MBF from [11C]acetate data is hampered
by incomplete extraction of the tracer, partial volume and
spillover effects, and recirculation of 11C-labelled
metabolites. Several strategies to (semi)quantify MBF
using [11C]acetate have been proposed. Gropler et al were
the first to demonstrate that initial myocardial uptake of
[11C]acetate serves as an indirect measure of regional
MBF.6 Subsequently, more complex tracer kinetic models
with arterial blood sampling have been used, taking into
account early [11C]acetate metabolism and applying
corrections for spillover and partial volume effects.7,8
Others have developed somewhat simplified kinetic
models using either an average metabolite correction9 or
disregarding recirculating 11C-labelled metabolites alto-
gether.6,10-12 Although all reported methods showed
reasonable correlation with MBF, it is as yet unclear
which method provides the most accurate estimate of
perfusion, as a direct comparison of the various methods is
lacking. Furthermore, the validity of the different models
in the presence of left ventricular (LV) hypertrophy
requires additional investigation, as increased wall
thickness and altered LV geometry affect partial volume
effects, and thus perfusion estimates. Therefore, the
objective of this study was to assess these models in both
normal subjects and patients with hypertrophic cardio-
myopathy (HCM) using a direct comparison with MBF as
measured with oxygen-15 labelled water.
MATERIALS AND METHODS
Subjects
Eighteen healthy subjects without relevant medical his-
tory and with normal physical examination, electrocardiogram,
and two-dimensional echocardiography, and 18 patients with
HCM were included in the study. HCM was diagnosed
according to the presence of a nondilated and hypertrophied
LV on two-dimensional echocardiography (maximal wall
thickness[15 mm in adult index patients or[13 mm in adult
relatives of an HCM patient) in the absence of any other sys-
temic or cardiac disease.13 All patients underwent coronary
angiography to exclude the presence of coronary artery dis-
ease. The use of betablockers or calcium channel blockers was
not discontinued during the study. All subjects gave written
informed consent, and the protocol was approved by the
Medical Ethics Review Committee of the VU University
Medical Centre, Amsterdam, The Netherlands.
PET Scanning Protocol
All PET scans were acquired under resting conditions
using an ECAT EXACT HR? scanner (Siemens/CTI, Knox-
ville, TN) in two-dimensional mode. A transmission scan was
performed using three rotating 68Ga/68Ge rod sources. Subse-
quently, 1100 MBq 15O-labelled water, dissolved in a 5 mL
saline solution, was injected intravenously, followed by a
40-mL saline solution flush at a rate of 4 mL/second. A
dynamic emission scan was acquired, consisting of 40 frames
with variable frame length (12*5, 12*10, 6*20, and
10*30 seconds) and with a total duration of 10 minutes.
Emission data were corrected for physical decay of 15O, dead
time, scatter, randoms and photon attenuation. After a period
of about 10 minutes to allow for decay of [15O]water,
550 MBq [11C]acetate was injected intravenously. At the same
time a dynamic emission scan was started, consisting of 29
frames (12*10, 3*20, 4*60, 3*120, and 7*300 seconds) and
with a total duration of 48 minutes. During all studies the rate
pressure product (RPP), being the product of systolic blood
pressure and heart rate, was monitored.
PET Data Analysis
Data were transferred to a SUN workstation (SUN
Microsystems Inc.) and analyzed using standard scanner soft-
ware, together with additional tracer kinetic analysis software
developed in MATLAB. [15O]water and [11C]acetate sino-
grams were reconstructed using filtered back projection with a
Hanning filter at .5 of the Nyquist frequency, resulting in a
transaxial spatial resolution of &7 mm full width at half-
maximum. Regions of interest (ROIs) were defined manually
on [11C]acetate short axis summed uptake images at basal,
midventricular and apical levels of the left ventricle, according
to a 13-segment model as described previously.14 This set of
ROIs was projected onto the dynamic [15O]water and
[11C]acetate images to generate time activity curves (TACs).
Figure 1 depicts a representative example of a myocardial
[11C]acetate TAC. Additional ROIs were defined in left atrium
and right ventricular chamber. This latter set of ROIs was also
projected onto the dynamic [15O]water and [11C]acetate ima-
ges to generate TACs of intravascular activity. These latter
TACs were used as image derived input functions and for
spillover correction of myocardial tissue TACs.
Calculation of Myocardial Blood Flow
Using the standard single tissue compartment model,
MBF (mL/minute/g of perfusable tissue) was determined for
all myocardial [15O]water TACs.15 Global MBF was calcu-
lated by grouping all ROIs, weighted for ROI volume.
Corrections were performed for both left and right ventricular
spillover effects, as described by Hermansen et al.16
For the determination of MBF from [11C]acetate data, four
different tracer kinetic models were investigated, which all have
been proposed and validated in humans previously. The design
and results of these studies are summarized in Table 1.
Because resting MBF is related to the RPP, corrected
resting MBF (MBFcorr), calculated as (MBF/RPP) 9 10.000,
was also determined for both the [15O]water and [11C]acetate
PET studies.
Method 1
Chan and co-workers related net myocardial uptake values
of [11C]acetate to MBF measurements acquired with
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[13N]ammonia.10 This approach is comparable to the one pro-
posed by Gropler et al.6 Net myocardial uptake of tracer was
assessed by dividing total myocardial tissue concentration at
4 minutes after tracer injection, by the area under the arterial
input curve over the first 4 minutes. The time point of 4 minutes
was chosen, as the myocardial [11C]acetate concentration was
highest, whereas the blood concentration was relatively low. No
corrections for spillover, partial volume effects and labelled
metabolites were made. The reported regression equation
between [11C]acetate obtained K1 values and [
13N]ammonia-
derived perfusion was K1 = .55 9 MBF ? .08.
Method 2
A more complex two tissue compartment model for
determining quantitative flow was proposed by Sun et al,8 as
depicted in Figure 2A. Clearance of 11C activity occurs from
both tissue compartments by the efflux of 11CO2. Arterial
blood samples were taken to correct the arterial input function
for recirculation-labelled metabolites. In addition, spillover
corrections were included, and fixed partial volume corrections
were applied assuming a uniform wall thickness of 1 cm in all
subjects. Total scan time was 15 minutes. The reported
regression equation between [11C]acetate obtained K1 values
and [13N]ammonia-derived perfusion was K1 = .726 9
MBF ? .152.
Method 3
Sciacca et al11 proposed a modified two tissue compart-
ment model for the assessment of MBF with [11C]acetate
(Figure 2B). It was hypothesized that [11C]acetate, after being
extracted from blood into myocardial tissue, is cleared as a
function of blood flow and/or metabolism. Spillover correc-
tions were included in the model, and fixed partial volume
corrections were applied assuming a recovery coefficient of
.65. The reported regression equation between [11C]acetate
obtained K1 values and [
15O]water-derived perfusion was
K1 = 1.057 9 MBF ? .27.
Method 4
Recently, van den Hoff et al9 proposed a simple single
tissue compartment model for the assessment of net myocar-
dial uptake with [11C]acetate (Figure 2C). This model
combines myocardial efflux of 11CO2 and other labelled
metabolites clearance of [11C]acetate in a single-rate constant
(k2). An average metabolite correction of the arterial input
function was applied based on arterial blood sample data from
Buck et al17 Data from the first 20 minutes after tracer injec-
tion were used to generate TACs. In addition, spillover and
partial volume corrections were included in the model. The
reported regression equation between K1 values and
[13N]ammonia-derived perfusion was K1 = 1 - .64e
-1.2/MBF.
Statistical Analysis
Results are displayed as mean ± standard deviation (SD).
Differences in [15O]water-derived flow values between study
groups were assessed by the unpaired Student’s t test. The
significance of differences between [15O]water and [11C]ace-
tate-derived estimates of MBF was assessed using the paired
Student’s t test. Correlations between [15O]water and
[11C]acetate derived estimates were evaluated using linear
regression analysis. Bland-Altman (BA) plots were generated
to evaluate methodological accuracy and to assess the limits of
agreement.18 The repeatability coefficient (RC) for the BA
plots was calculated as 1.96 times the SD of the mean differ-
ence between the two methods. P values\.05 were considered
statistically significant.
RESULTS
Baseline characteristics of both study groups are
presented in Table 2. No significant differences were
present between the control and HCM group for sex, body
surface area (BSA), LV end-diastolic volume (LVEDV),
LV end-systolic volume (LVESV) and LV ejection frac-
tion (LVEF), whereas age and LV mass (LVM) were
significantly increased in patients with HCM (P = .01
and P \ .001, respectively). Nearly all HCM patients
were using one or more drugs (n = 15 betablockers,
n = 6 calcium channel blockers, n = 5 both).
Myocardial Blood Flow Measurements
Using [15O]Water
MBF values derived from [15O]water scans averaged
.98 ± .26 mL/minute/g for the entire study population
(Table 3), with a range from .57 to 1.56 mL/minute/g.
Figure 1. [11C]acetate time activity curves for a normal
subject. Note the peak of myocardial activity, indicating a
profound effect of spillover from blood to myocardium
(indicated by the arrow).
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Average MBF values were not significantly different
between healthy individuals (1.06 ± .29 mL/minute/g)
and patients with HCM (.90 ± .21 mL/minute/g)
(P = .07). On average, the RPP between [15O]water
(7911 mmHg/minute) and the [11C]acetate scans
Figure 2. (A) Two tissue compartment model as proposed by
Sun et al.8 In all models, K1 represents the influx into
compartment 1. k2 represents the rate constant of clearance of
CO2 from compartment 1 and reflects the oxidative flux
through the tricarboxylic acid cycle. k3 represents the rate
constant of clearance of CO2 efflux from compartment 2. (B)
Two tissue compartment model as proposed by Sciacca et al.11
k2 represents the transformation of tracer to metabolic products
which are trapped in compartment 2. Washout of tracer from
compartment 1 to blood is depicted as a function of MBF (f).
(C) One tissue compartment model as proposed by van den
Hoff et al.9 k2 represents the rate constant for tracer washout to
blood and transferal of 11C to metabolic products. TCA cycle,
Tricarboxylic acid cycle; AA, amino acids; a-Keto, a-Ketoglu-
tarate; Glu, Glutamate; Gln, Glutamine.
Table 2. Baseline characteristics
Controls
(N 5 18)
HCM
(N 5 18) P
Sex 8 men 9 men .85
Age (year) 44 ± 15 57 ± 15 .01
BSA (m2) 2.0 ± .2 2.1 ± .2 .72
LVM (g) 94 ± 20 192 ± 80 .001
LVEDV (mL) 182 ± 29 188 ± 32 .55
LVESV (mL) 73 ± 19 74 ± 21 .88
LVEF (%) 61 ± 5 60 ± 7 .90
HCM, Hypertrophic cardiomyopathy; BSA, body surface area;
LVM, left ventricular mass; LVEDV, left ventricular end-diastolic
volume; LVESV, left ventricular end-systolic volume; LVEF, left
ventricular ejection fraction.
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(7979 mmHg/minute) was comparable (P = .67),
whereas the variation of the RPP between the successive
scans was 2 ± 8%.
Myocardial Blood Flow Measurements
Using [11C]Acetate
MBF was calculated from the [11C]acetate scans
using the four methods described above. Results for both
MBF and K1 are given (Table 3), in addition to the
differences between [15O]water and [11C]acetate
obtained mean MBF (Table 4). K1 represents net myo-
cardial uptake of [11C]acetate, whilst MBF represents
the corresponding flow value calculated using the rela-
tionship between K1 and MBF, as provided in each of
the original validation studies.
Method 1
For Method 1, MBF obtained with [11C]acetate
averaged .43 ± .09 mL/minute/g in the control group and
.48 ± .1 mL/minute/g in the HCM group. The correlation
coefficients between [15O]water and [11C]acetate-derived
values were r = .76 and r = .80 in control and HCM
groups, respectively (both P \ .001). Corresponding
regression plots are shown in Figure 3A. Bland-Altman
analysis of MBF demonstrated a mean difference of
.53 ± .22 mL/minute/g between [15O]water and
[11C]acetate significantly different from zero (P \ .001)
(Figure 3B), whilst the RC equalled .43. Figure 3C and D
depicts the regression for K1 values against MBF with the
corresponding Bland-Altman plot. After correction for
the RPP, the regression line and correlation coefficient
between [15O]water and [11C]acetate MBFcorr were
y = .197x ? .20, r = .70 for the control group and
y = .318x ? .09, r = .78 for the HCM group (both
P \ .001).
Method 2
For Method 2, MBF obtained with [11C]acetate
averaged .34 ± .11 mL/minute/g in the control group
and .40 ± .12 mL/minute/g in the HCM group. The
correlation coefficients between [15O]water and
[11C]acetate derived values were r = .85 for both control
and HCM groups (both P \ .001). Corresponding
regression plots are shown in Figure 4A. Bland-Altman
analysis of MBF (Figure 4B) demonstrated a mean dif-
ference of .61 ± .20 mL/minute/g between [15O]water
and [11C]acetate derived MBF values significantly dif-
ferent from zero (P \ .001), whilst the RC equalled .41.
Figure 4C and D depicts the regression for K1 against
MBF with the corresponding Bland-Altman plot. The
regression line and correlation coefficient between
[15O]water and [11C]acetate MBFcorr were y = .251x ?
.16, r = .82 for the control group and y = .446x ? .01,
r = .82 for the HCM group (both P \ .001).
Method 3
The results from Method 3 showed an average MBF
obtained with [11C]acetate of 1.25 ± .33 mL/minute/g in
the control group and 1.42 ± .38 mL/minute/g in the
HCM group. The correlation coefficients between
[15O]water and [11C]acetate derived values were r = .67
and r = .73 in control and HCM groups, respectively
(both P \ .005). Corresponding regression plots are
shown in Figure 5A. Bland-Altman analysis of MBF
(Figure 5B) demonstrated a mean difference of -.29 ±
.26 mL/minute/g between [15O]water and [11C]acetate
derived MBF values significantly different from zero
(P \ .001), whilst the RC equalled .59. Figure 5C and D
depicts the regression between K1 and MBF with the
corresponding Bland-Altman plot. The regression line
and correlation coefficient between [15O]water and
[11C]acetate MBFcorr were y = .843x ? .51, r = .66 for
the control group and y = 1.532x ? .09, r = .77 for the
HCM group (both P \ .001).
Method 4
Using Method 4, [11C]acetate-derived MBF values
averaged .88 ± .25 mL/minute/g in the control group
and .83 ± .22 mL/minute/g in the HCM group. The
correlation coefficients between [15O]water and
[11C]acetate derived values were r = .86 and r = .85 in
Table 4. Differences between mean [15O]water and [11C]acetate obtained MBF values
Study group
[15O]water MBF 2 [11C]acetate MBF
Method 1 Method 2 Method 3 Method 4
Controls .63 ± .23 .72 ± .21 -.22 ± .25 .18 ± .15
HCM .43 ± .14 .51 ± .12 -.51 ± .30 .07 ± .12
MBF, Myocardial blood flow; HCM, hypertrophic cardiomyopathy.
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control and HCM groups, respectively (both P \ .001).
Corresponding regression plots are shown in Figure 6A.
Bland-Altman analysis of MBF (Figure 6B) demon-
strated a mean difference .13 ± .14 mL/minute/g
between [15O]water and [11C]acetate derived MBF val-
ues significantly different from zero (P \ .001), whilst
the RC equalled .29. Figure 6C and D depicts the
regression between K1 and MBF with the corresponding
Bland-Altman plot. The regression line and correlation
coefficient between [15O]water and [11C]acetate
MBFcorr were y = .761x ? .10, r = .84 for the control
group and y = .866x ? .03, r = .85 for the HCM group
(both P \ .001).
DISCUSSION
This study was performed to evaluate different
methods for quantifying MBF using [11C]acetate. To
this end, paired [15O]water and [11C]acetate studies were
performed in both healthy subjects and patients with
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Figure 3. (A) Regression analysis and (B) corresponding Bland-Altman plot for MBF derived
from [11C]acetate against MBF derived from [15O]water for Method 1. (C) Regression analysis, and
(D) corresponding Bland-Altman plot for K1 values obtained from [
11C]acetate against MBF
derived from [15O]water. The horizontal solid lines in the Bland-Altman plots represent mean
differences and 95% confidence limits (±2 SD). Note the significant trend of progressively
increasing differences as a function of increasing MBF. TAC, Time activity curve; HCM,
hypertrophic cardiomyopathy.
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HCM. Amongst the four methods evaluated, the most
accurate [11C]acetate-derived MBF values were
obtained using a single tissue compartment model with
standard correction for circulating labelled metabolites,
together with partial volume and spillover corrections as
described by van den Hoff et al (Method 4). MBF values
obtained with this method showed strong correlations
with [15O]water-derived MBF values in both control and
HCM groups (Figure 6A) with a slope near unity and an
Y-intercept close to zero. On average, the RPP did not
significantly differ between the successive scans,
whereas the regression lines and correlation coefficients
between [15O]water and [11C]acetate MBF after cor-
rection for the RPP were generally comparable, both
indicating stable hemodynamic conditions. These results
confirm the potential value of [11C]acetate as a quanti-
tative PET perfusion tracer.
Despite the fact that all four investigated methods
displayed moderate-to-strong correlations in both study
groups, it should be noted that for the other three
methods, the slopes of the regression lines deviated from
unity and/or Y-intercepts were different from zero.
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Figure 4. (A) Regression analysis and (B) corresponding Bland-Altman plot for MBF derived
from [11C]acetate against MBF derived from [15O]water for Method 2. Note the linear relationship
with equally strong correlation coefficients between both parameters over flow ranges from .5 to
1.5 mL/minute/g in both study groups. (C) Regression analysis and (D) corresponding Bland-
Altman plot for K1 values obtained from [
11C]acetate against MBF derived from [15O]water. The
horizontal solid lines in the Bland-Altman plots represent mean differences and 95% confidence
limits (±2 SD). Note the significant trend of progressively increasing differences as a function of
increasing MBF. TAC, Time activity curve; HCM, hypertrophic cardiomyopathy.
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These results can for the large part be attributed to the
following factors. First, based on previous investiga-
tions,19 Methods 1 and 3 assume that release of 11C-
labelled metabolites, such as amino acids, TCA cycle
intermediates and 11CO2, during the initial myocardial
uptake phase is minimal. However, it has been shown
that, within the first 2 and 4 minutes, nearly 14% and
42% of radioactivity, respectively, can be ascribed to
11C-labelled metabolites.8 These labelled metabolites in
arterial blood are mainly produced and released by non-
cardiac tissue. The contribution of these radioactive
metabolites to total blood 11C activity will result in an
overestimation of the arterial input with subsequent
underestimation of actual myocardial net tracer uptake.
Second, several studies have shown that myocardial
extraction of [11C]acetate is incomplete, decreasing with
increasing myocardial perfusion.8,9,19 Recent data sug-
gest that the extraction fraction of [11C]acetate ranges
from 90% to 80% within the flow range of .5-1.0 mL/
minute/g.8,9 Therefore, K1, being the product of flow and
extraction fraction, will always be lower than MBF.
Despite the fact that Methods 1-3 correct for incomplete
extraction of [11C]acetate based on empirically obtained
relationships between actual perfusion and K1, they
assume this relation to be linear. However, it is well
known that extraction fraction itself is a function of flow
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Figure 5. (A) Regression analysis and (B) corresponding Bland-Altman plot for MBF derived
from [11C]acetate against MBF derived from [15O]water for method 3. (C) Regression analysis and
(D) corresponding Bland-Altman plot for K1 values obtained from [
11C]acetate against MBF
derived from [15O]water. The dashed lines represent zero difference, whereas mean differences and
95% confidence limits (±2 SD) are represented by the horizontal solid lines. TAC, Time activity
curve; HCM, hypertrophic cardiomyopathy.
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and, consequently, the relationship between K1 and
MBF is non-linear, as clearly demonstrated by van den
Hoff et al9 Therefore, it can be postulated that describing
the exponential relationship, between [11C]acetate
extraction and flow, in a linear fashion, could result in
less accurate flow estimations, where overestimation
occurs within the lower flow range and underestimation
can be observed within the higher flow ranges. It needs
to be emphasized, however, that the use of an exponential
function to describe the relationship between K1 and
MBF (Method 4), did not increase the accuracy of MBF
estimates with [11C]acetate in the control group (K1
vs [15O]water MBF, r = .87 and [11C]acetate MBF
vs [15O]water MBF, r = .86), or the HCM group (K1 vs
[15O]water MBF, r = .85 and [11C]acetate MBF vs
[15O]water MBF, r = .85). Although the introduction
of parameter estimation bias therefore seems limited
when studies are performed under baseline conditions,
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Figure 6. (A) Regression analysis and (B) corresponding Bland-Altman plot for MBF derived from
[11C]acetate against MBF derived from [15O]water for Method 4. Note the linear relationship with
strong correlation coefficients between both parameters over flow ranges from .5 to 1.5 mL/minute/g
in both study groups. (C) Regression analysis, and (D) corresponding Bland-Altman plot for
K1 values obtained from [
11C]acetate against MBF derived from [15O]water. The dashed lines
represent zero difference, whereas mean differences and 95% confidence limits (±2 SD) are
represented by the horizontal solid lines. TAC, Time activity curve; HCM, hypertrophic
cardiomyopathy.
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correction for [11C]acetate extraction in a non-linear
fashion seems warranted in the higher flow ranges to avoid
underestimation of perfusion, in analogy to other similar
PET perfusion tracers such as [13N]ammonia9 and
[82Rb].20
For Methods 1-3, average [11C]acetate-derived K1
and MBF values were consistently higher for the HCM
group as compared with the control group, contrary to
results obtained with [15O]water. This finding might be
due to a number of factors. First, employing an average
metabolite correction may improve the accuracy of
arterial input functions, but it inherently assumes that
[11C]acetate metabolism is not affected by myocardial
pathology. Sun et al have shown that inter-individual
differences in [11C]acetate metabolism are relatively
small (range of 10-15%) in healthy subjects, which is a
prerequisite for the implementation of an average
metabolite correction formula.8 Whether this assump-
tion holds true for patients with HCM, however, is
unclear. Second, an altered myocardial metabolic state
due to myocardial pathology may result in a change in
extraction fraction of [11C]acetate and consequently an
altered relationship between K1 and MBF.
21 Finally,
whereas tracer kinetics of [15O]water allow for an
accurate model-based correction of partial volume
effects,15 the tracer kinetics of [11C]acetate do not. Since
myocardial wall thickness is a determinant of partial
volume effects, patients with HCM generally show
higher measured myocardial [11C]acetate concentrations
than healthy individuals. Therefore, the difference in
average [11C]acetate-derived MBF values between
control and HCM study groups could also be explained
by higher measured [11C]acetate concentrations due to
increased myocardial mass in the latter group.
Several additional remarks can be made considering
the results obtained with the four methods investigated.
Using Method 1, Chan and colleagues reported strong
correlations (r = .87, P \ .001) between [11C]acetate-
derived K1 values and [
13N]ammonia-derived MBF
values. The present results, however, showed moderate
correlation coefficients in both study groups, together
with a large systematic underestimation of actual per-
fusion values. However, no corrections for spillover
from myocardium to blood were applied. As depicted in
Figure 1, at 4 minutes after tracer injection, total myo-
cardial [11C]activity is substantially higher than in
arterial blood, and myocardium to blood spillover would
lead to an overestimation of the arterial input. In addi-
tion, early myocardial release of 11CO2 at 4 minutes will
result in underestimation of true myocardial tracer
uptake.5,19 Therefore, according to this method, net
myocardial uptake of [11C]acetate is increasingly
underestimated with increasing myocardial perfusion.
Using Method 2, Sun et al report a strong correla-
tion (r = .93, P \ .001) between [11C]acetate-derived
K1 values and [
13N]ammonia-derived MBF values.8 The
correlation coefficient for this study was only marginally
weaker. Nevertheless, the regression line describing the
relationship between [11C]acetate and [15O]water
obtained MBF (Controls, y = .302x ? .02 and HCM,
y = .515x - .07) demonstrates large systematic under-
estimation of actual MBF values. Although the cause for
the discrepancy remains to be elucidated, the relation-
ship between K1 and MBF found in the study population
of Sun et al could not be reproduced in this study pop-
ulation. Differences in patient characteristics may have
contributed to these observations and warrants further
investigation.
Method 3 resulted in moderate correlation coeffi-
cients in both study groups (controls, r = .73 and HCM,
r = .67), whereas the slope of the regression line (con-
trols, y = .74x ? .5 and HCM, 1.43x ? .11) showed
substantial overestimation of actual perfusion values.
This observation could be attributed to the fixed recov-
ery coefficient of .65, a correction for partial volume
effects that is inaccurate with changes in myocardial
thickness. Furthermore, the present tracer kinetic model
is only applicable to fit data from the initial 3 minutes
after tracer injection, thereby possibly limiting the
statistical accuracy of MBF estimations.
Employing Method 4 yielded strong correlations
with [15O]water-derived MBF in both control and
HCM groups (r = .86 and r = .85), although they
were weaker than reported by van den Hoff et al
(r = .96).9 For both study groups, the regression line
between [11C]acetate- and [15O]water-derived MBF
values had a slope of almost unity and an Y-intercept
close to zero, whereas Bland-Altman analysis showed a
small systematic underestimation. In addition, this
method was the only one that measured a lower mean
MBF in the HCM group than in the healthy control
group. These results suggest that the assessment of
MBF using [11C]acetate is in fairly good agreement
with actual perfusion, and of the models investigated
that of van den Hoff et al yields the most accurate
estimates.9
The high agreement between [11C]acetate- and
[15O]water-obtained MBF introduces the possibility of a
dual tracer research protocol in which resting MBF and
MVO2 can be acquired simultaneously in a single
dynamic [11C]acetate PET scan, whereas an additional
[15O]water scan during maximal vasodilatation
could provide with the flow reserve. However, the
reproducibility of this approach in repeated investiga-
tions, i.e. test-retest variability, needs to be assessed in
future studies.
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Study Limitations
The range of MBF values in this study was relatively
narrow and obtained under baseline conditions only.
Additional studies under a wider range of myocardial flow
conditions (i.e., induced by beta-blockers, dipyridamole,
or dobutamine) are needed to investigate the consistency,
as well as intra- and interobserver reproducibility of MBF
quantification with [11C]acetate PET. Due to the apparent
nonlinear relationship between K1 and MBF, these studies
are especially important for hyperemic flow values. Fur-
thermore, additional [15O]water PET data on hyperemic
flow values would enable the calculation of the myocar-
dial flow reserve with a hybrid tracer approach, i.e., the
ratio between [15O]water hyperemic and [11C]acetate
resting flow, in direct comparison to the standardized
single tracer approach, i.e., [15O]water only. Finally, in
this study, healthy control subjects and patients with HCM
were investigated. Consequently, use of [11C]acetate to
measure MBF in patients with other myocardial pathol-
ogies, such as coronary artery disease, should first be
evaluated.
CONCLUSION
[11C]acetate enables quantification of MBF in fairly
good agreement with actual perfusion values in both
healthy individuals and patients with HCM over physi-
ological flow ranges under baseline conditions. Of the
investigated methodologies, the use of a single com-
partment model with a standardized recirculating
metabolite, as well as partial volume and spillover cor-
rections most accurately reflects MBF as measured with
[15O]water.
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